BROOKFIELD, NEWS, Oct. 06, 2026 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners will hold its third quarter 2026 conference call and webcast on Friday, November 6, 2026, at 9:00 a.m. (ET).

Results will be released that morning before 7:00 a.m. (ET) and will be available on our website at https://bip.brookfield.com.

Participants can join by conference call or webcast.

Conference Call

  • Please pre-register at: BIP2026Q3ConferenceCall
  • Upon registering, you will be emailed a dial-in number and unique PIN. This process will bypass the operator and avoid the queue.

Webcast

About Brookfield Infrastructure

Brookfield Infrastructure is a leading global infrastructure company that owns and operates high-quality, long-life assets in the utilities, transport, midstream and data sectors across the Americas, Asia Pacific and Europe. We are focused on assets that have contracted and regulated revenues that generate predictable and stable cash flows. Investors can access its portfolio either through Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN), a Bermuda-based limited partnership, or Brookfield Infrastructure Corporation (NYSE, TSX: BIPC), a Canadian corporation. Further information is available at https://bip.brookfield.com.

Brookfield Infrastructure is the flagship listed infrastructure company of Brookfield Asset Management, a global alternative asset manager, headquartered in New York with over $1 trillion of assets under management. For more information, go to https://brookfield.com.

Contact Information

Media
John Hamlin
Director,
Communications
Tel: +44 204 557 4334
Email: john.hamlin@brookfield.com 
Investor Relations
Stephen Fukuda
Managing Director,
Corporate Development & Investor Relations
Tel: +1 (416) 956 5129
Email: stephen.fukuda@brookfield.com

Transactions during 29 September 2026 – 05 October 2026
On 7 May 2026, Alm. Brand A/S announced a share buy-back program of up to DKK 593 million, as described in company announcement no. 23/2026.

The program is carried out in accordance with the Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.

The following transactions were made under the share buy-back program 29 September – 05 October 2026:

  Number of shares bought Average
purchase price
Amount (DKK)
Accumulated, last announcement
29 September 2026
30 September 2026
01 October 2026
02 October 2026
05 October 2026
14,349,667
240,000
 275,000
 200,000
 122,000
 18,683
16.45
16.26
16.38
16.15
16.11
16.78
236,115,285
3,901,392
4,504,748
3,230,000
1,964,871
313,416
Total, 29 September – 05 October 2026 855,683 16.26 13,914,427
Accumulated under the program 15,205,350 16.44 250,029,712

With the transactions stated above Alm. Brand A/S holds a total of 47,942,022 own shares, corresponding to 3.41% of the total number of outstanding shares.

Contact
Please direct any questions regarding this announcement to:

Investors and equity analysts:                                 

VP, Head of Investor Relations & ESG                    
Mads Thinggaard                                                       
Mobile no, +45 2025 5469                                      

Attachments

Transactions during 29 September 2026 – 05 October 2026
On 7 May 2026, Alm. Brand A/S announced a share buy-back program of up to DKK 593 million, as described in company announcement no. 23/2026.

The program is carried out in accordance with the Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.

The following transactions were made under the share buy-back program 29 September – 05 October 2026:

  Number of shares bought Average
purchase price
Amount (DKK)
Accumulated, last announcement
29 September 2026
30 September 2026
01 October 2026
02 October 2026
05 October 2026
14,349,667
240,000
 275,000
 200,000
 122,000
 18,683
16.45
16.26
16.38
16.15
16.11
16.78
236,115,285
3,901,392
4,504,748
3,230,000
1,964,871
313,416
Total, 29 September – 05 October 2026 855,683 16.26 13,914,427
Accumulated under the program 15,205,350 16.44 250,029,712

With the transactions stated above Alm. Brand A/S holds a total of 47,942,022 own shares, corresponding to 3.41% of the total number of outstanding shares.

Contact
Please direct any questions regarding this announcement to:

Investors and equity analysts:                                 

VP, Head of Investor Relations & ESG                    
Mads Thinggaard                                                       
Mobile no, +45 2025 5469                                      

Attachments

Three months after its official kick-off in Brussels, the Q-PLANET Pilot Line is moving from vision to execution, with Pasqal steering 28 partners from 11 European countries to build a resilient European supply chain for neutral-atom quantum technologies

PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) — Pasqal (NASDAQ: PSQL), a global leader in neutral-atom quantum computing, is coordinating the implementation of Q-PLANET (Quantum Pilot Line for production of Advanced chips for Neutral atom European Technologies), co-funded by the EU Chips Joint Undertaking (Chips JU) and National/Regional authorities. Backed by €50 million over three years, the consortium brings together 28 partners from 11 European countries to develop industrial-grade chip components for neutral-atom quantum computing, sensing, and communication.

A Concrete Commitment to Europe’s Quantum Industrial Ambitions and Strategic Autonomy

Pasqal’s leadership of Q-PLANET reflects the company’s concrete commitment to the European Union’s industrial quantum ambitions, in line with the upcoming EU Quantum Act. Through Q-PLANET, Pasqal is delivering one of the flagship initiatives of the European Quantum Strategy, aimed at supporting the large-scale industrialization of quantum technologies across the European Union.

Through this pan-European collaborative effort, Q-PLANET will help establish the foundations for a resilient, state-of-the-art European quantum supply chain, strengthening the broader resilience and strategic autonomy of the European Union, while reinforcing its global competitiveness in quantum technologies.

Over the next three years, the consortium will develop critical industrial-grade chip-based components for neutral-atom quantum technologies, including lasers at four key wavelengths (461 nm, 698 nm, 795 nm and 1013 nm), atom chips for quantum sensing and computing, and microfabricated vapor cells for atomic clocks and field sensors. Q-PLANET will also establish a pathway from laboratory research to industrial fabrication through the development of standardized Process Design Kits (PDKs) and Assembly Design Kits (ADKs), alongside energy-efficiency monitoring assessment across the production cycle of quantum technologies. Within this effort, Pasqal will notably lead the development activities dedicated to chip-based laser sources at 1013nm, one of the project’s core technology streams. Pasqal will also act as an end-user of the microfabricated vapor cells and laser sources, providing top-level specifications for their development, testing and validation.

Strengthening Europe’s Neutral-atom Ecosystem & Building a European Quantum Market around User Needs

Under Pasqal’s leadership, Q-PLANET will strengthen the European industrial and scientific neutral-atom ecosystem by bringing together leading research and technology organizations, industry partners and academic research groups. With 28 partners from 11 European countries, the consortium will foster synergies and partnerships across academia and industry, helping connect scientific research, industrial capabilities and the development of real-world quantum applications.

Q-PLANET will also contribute to the development of a European quantum market by addressing the needs of European users. Through advancements in quantum computing, quantum sensing and quantum communications, the pilot line will help lay the foundations for future quantum use case applications in sectors where societal, economic and scientific interests are particularly strong, including drug discovery and materials discovery. By connecting advances in quantum hardware and manufacturing with concrete application requirements, Q-PLANET will help bring European quantum technologies closer to practical deployment and adoption.

“Three months after our kick-off in Brussels, Q-PLANET has moved from ambition to execution. Together with our 28 partners, we are building a European supply chain for neutral-atom technologies, while bringing quantum industrialization closer to concrete user needs,” said Loïc Henriet, CTO of Pasqal. “Q-PLANET reflects Pasqal’s commitment to Europe’s quantum ambitions, bridging large-scale industrialization rooted in resilient capabilities with real-world application to build a globally competitive and resilient European quantum industry.”

Contact:
Investors 
investors@pasqal.com

Media
pr@pasqal.com

About Pasqal
Pasqal (Nasdaq: PSQL) helps organizations tackle problems that are difficult or impossible to solve with conventional computing methods alone. Founded in 2019 on Nobel Prize–winning research, Pasqal builds and operates neutral-atom quantum computers, delivered with a full software stack, for industry, science, and governments. Pasqal’s production-ready systems are available both on-premises and through the cloud, enabling organizations to harness quantum computing without requiring in-house quantum expertise. A single hardware platform supports analog workloads today and is designed to evolve toward fault-tolerant quantum computing in the future.

Headquartered in France with operations globally, Pasqal’s quantum computing systems are used by customers across energy, financial services and advanced materials to address complex challenges. Pasqal’s customers include Saudi Aramco, Crédit Agricole CIB, LG Electronics and supported by partnerships with NVIDIA and IBM (Pasqal is part of the IBM Quantum Network).

In Europe, under the EuroHPC Joint Undertaking procurement process, Pasqal has delivered three quantum processing units to European High-Performance Computing Centers in France (TGCC), Germany (Forschungszentrum Jülich) and Italy (CINECA). Pasqal is the elected European Convenor of CEN/CENELEC JTC22 European standardization WG3 on quantum computing and simulation, representing 34 European countries. It is also a member of the French governmental delegation to the ISO/IEC JTC3 international standardization committee on quantum technologies.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or Chips Joint Undertaking. Neither the European Union nor the granting authority can be held responsible for them. The project is supported by Chips JU and its members including top-up funding by France 2030, European Regional Development Fund (ERDF), Ministry of Science, Research and Arts Baden-Württemberg, Business Finland and The Austrian Research Promotion Agency (FFG).

Read more about Q-PLANET: www.q-planet.eu

Three months after its official kick-off in Brussels, the Q-PLANET Pilot Line is moving from vision to execution, with Pasqal steering 28 partners from 11 European countries to build a resilient European supply chain for neutral-atom quantum technologies

PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) — Pasqal (NASDAQ: PSQL), a global leader in neutral-atom quantum computing, is coordinating the implementation of Q-PLANET (Quantum Pilot Line for production of Advanced chips for Neutral atom European Technologies), co-funded by the EU Chips Joint Undertaking (Chips JU) and National/Regional authorities. Backed by €50 million over three years, the consortium brings together 28 partners from 11 European countries to develop industrial-grade chip components for neutral-atom quantum computing, sensing, and communication.

A Concrete Commitment to Europe’s Quantum Industrial Ambitions and Strategic Autonomy

Pasqal’s leadership of Q-PLANET reflects the company’s concrete commitment to the European Union’s industrial quantum ambitions, in line with the upcoming EU Quantum Act. Through Q-PLANET, Pasqal is delivering one of the flagship initiatives of the European Quantum Strategy, aimed at supporting the large-scale industrialization of quantum technologies across the European Union.

Through this pan-European collaborative effort, Q-PLANET will help establish the foundations for a resilient, state-of-the-art European quantum supply chain, strengthening the broader resilience and strategic autonomy of the European Union, while reinforcing its global competitiveness in quantum technologies.

Over the next three years, the consortium will develop critical industrial-grade chip-based components for neutral-atom quantum technologies, including lasers at four key wavelengths (461 nm, 698 nm, 795 nm and 1013 nm), atom chips for quantum sensing and computing, and microfabricated vapor cells for atomic clocks and field sensors. Q-PLANET will also establish a pathway from laboratory research to industrial fabrication through the development of standardized Process Design Kits (PDKs) and Assembly Design Kits (ADKs), alongside energy-efficiency monitoring assessment across the production cycle of quantum technologies. Within this effort, Pasqal will notably lead the development activities dedicated to chip-based laser sources at 1013nm, one of the project’s core technology streams. Pasqal will also act as an end-user of the microfabricated vapor cells and laser sources, providing top-level specifications for their development, testing and validation.

Strengthening Europe’s Neutral-atom Ecosystem & Building a European Quantum Market around User Needs

Under Pasqal’s leadership, Q-PLANET will strengthen the European industrial and scientific neutral-atom ecosystem by bringing together leading research and technology organizations, industry partners and academic research groups. With 28 partners from 11 European countries, the consortium will foster synergies and partnerships across academia and industry, helping connect scientific research, industrial capabilities and the development of real-world quantum applications.

Q-PLANET will also contribute to the development of a European quantum market by addressing the needs of European users. Through advancements in quantum computing, quantum sensing and quantum communications, the pilot line will help lay the foundations for future quantum use case applications in sectors where societal, economic and scientific interests are particularly strong, including drug discovery and materials discovery. By connecting advances in quantum hardware and manufacturing with concrete application requirements, Q-PLANET will help bring European quantum technologies closer to practical deployment and adoption.

“Three months after our kick-off in Brussels, Q-PLANET has moved from ambition to execution. Together with our 28 partners, we are building a European supply chain for neutral-atom technologies, while bringing quantum industrialization closer to concrete user needs,” said Loïc Henriet, CTO of Pasqal. “Q-PLANET reflects Pasqal’s commitment to Europe’s quantum ambitions, bridging large-scale industrialization rooted in resilient capabilities with real-world application to build a globally competitive and resilient European quantum industry.”

Contact:
Investors 
investors@pasqal.com

Media
pr@pasqal.com

About Pasqal
Pasqal (Nasdaq: PSQL) helps organizations tackle problems that are difficult or impossible to solve with conventional computing methods alone. Founded in 2019 on Nobel Prize–winning research, Pasqal builds and operates neutral-atom quantum computers, delivered with a full software stack, for industry, science, and governments. Pasqal’s production-ready systems are available both on-premises and through the cloud, enabling organizations to harness quantum computing without requiring in-house quantum expertise. A single hardware platform supports analog workloads today and is designed to evolve toward fault-tolerant quantum computing in the future.

Headquartered in France with operations globally, Pasqal’s quantum computing systems are used by customers across energy, financial services and advanced materials to address complex challenges. Pasqal’s customers include Saudi Aramco, Crédit Agricole CIB, LG Electronics and supported by partnerships with NVIDIA and IBM (Pasqal is part of the IBM Quantum Network).

In Europe, under the EuroHPC Joint Undertaking procurement process, Pasqal has delivered three quantum processing units to European High-Performance Computing Centers in France (TGCC), Germany (Forschungszentrum Jülich) and Italy (CINECA). Pasqal is the elected European Convenor of CEN/CENELEC JTC22 European standardization WG3 on quantum computing and simulation, representing 34 European countries. It is also a member of the French governmental delegation to the ISO/IEC JTC3 international standardization committee on quantum technologies.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or Chips Joint Undertaking. Neither the European Union nor the granting authority can be held responsible for them. The project is supported by Chips JU and its members including top-up funding by France 2030, European Regional Development Fund (ERDF), Ministry of Science, Research and Arts Baden-Württemberg, Business Finland and The Austrian Research Promotion Agency (FFG).

Read more about Q-PLANET: www.q-planet.eu

Purchases are the next step in the Company’s $1.2 billion dual treasury capital plan targeting $827 million in Bitcoin and $800 million in AI assets by FY2031.

SINGAPORE, Oct. 06, 2026 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group”, “GNS” or the “Company”), a leading AI-powered education group, today announced that it has recommenced its Bitcoin Treasury purchases, acquiring 10 Bitcoin for approximately $854,000 at an average price of $85,364 per BTC between October 2 and October 5, 2026.

The purchases mark a strategic milestone for the Company as it takes the next step in executing its Board-approved $1.2 billion dual treasury capital plan, announced on August 27, 2026. The plan targets $827 million allocated to Bitcoin and $800 million to AI assets, with a goal of reaching $2 billion in total assets by FY2031.

The recommencement of Bitcoin purchases follows the ruling by U.S. Court of Appeals for the Second Circuit on August 31, 2026, vacating the preliminary injunction that had previously blocked the Company from issuing shares, raising funds, and purchasing Bitcoin.

The Company had previously indicated that it intended to recommence Bitcoin purchases in October 2025, citing the Company’s belief that this coincided with the early stages of Bitcoin’s historic four-year halving-cycle uptrend.

The Company intends to continue accumulating Bitcoin on an ongoing basis as part of its dual treasury strategy, alongside its planned accumulation of AI stocks. To date, the Company has announced look-through interests in OpenAI, Anthropic, Databricks, SpaceX (held prior to and following its IPO on June 12, 2026) and other Pre-IPO frontier AI companies.

The Company intends to fund purchases for its dual treasury through a balanced mix of operating cash flow, previously-announced plans for the issuance of perpetual preferred securities and prudent use of its At-The-Market Program facility, designed to maximise Net Asset Value Per Share (NAVPS). The Company currently has no plans to fund purchases with debt financing, or to hypothecate any of its Bitcoin or AI stocks held in its dual treasury.

Roger James Hamilton, CEO of Genius Group, said “This week’s purchase of Bitcoin, while modest, is a signal to our shareholders and to the market that we are recommencing our Bitcoin accumulation strategy at what we believe is the early stages of Bitcoin’s next major uptrend.”

“We are educating our students on the ‘ABC’s of the future: AI, Blockchain and Community, in which we believe ownership in the future AI-powered digital workforce and Blockchain-based digital economy is a key component to wealth creation in a post-Singularity world. Our dual treasury strategy is our way of leading by example, as we continue to pursue our mission of preparing humanity for a fast changing future.”

About Genius Group

Genius Group (NYSE: GNS) is a global education group delivering AI powered, education and acceleration solutions for the future of work. Genius Group serves 6 million users in over 100 countries through its Genius City model and online digital marketplace of AI training, AI tools and AI talent. It provides personalized, entrepreneurial AI pathways combining human talent with AI skills and AI solutions at the individual, enterprise and government level. To learn more, please visit geniusgroup.ai

Forward-Looking Statements 

Statements made in this press release include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by the use of words such as “may,” “will”, “plan,” “should,” “expect,” “anticipate,” “estimate,” “continue,” or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the heading “Risk Factors” in the Company’s Annual Reports on Form 20-F, as may be supplemented or amended by the Company’s Reports of a Foreign Private Issuer on Form 6-K. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise. No information in this press release should be construed as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

Contacts
For enquiries, contact investor@geniusgroup.ai

Strengthens Board with science and technology pioneer responsible for establishing modern biometric technologies aligned with ROC’s Vision AI growth strategy

Dr. Jain’s foundational research in pattern recognition and biometrics has helped shape the identity technologies used across government, security, and commercial applications

Denver, CO, Oct. 06, 2026 (GLOBE NEWSWIRE) — Rank One Computing Corporation d/b/a ROC, (Nasdaq: ROC) (“ROC” or the “Company”), a U.S. leader in Vision AI, building unified biometric, video analytics, and digital evidence solutions, announces the appointment of Dr. Anil K. Jain, one of the field’s foremost authorities in pattern recognition, computer vision, and biometrics, to its Board of Directors (the “Board”), effective as of October 5, 2026.

“Dr. Jain has helped define how modern biometric technology is built, measured, and put to use. I have had the privilege of working with Anil for nearly two decades and have seen firsthand the rigor and practical perspective that have made his work so influential,” said B. Scott Swann, Chief Executive Officer of ROC. “His expertise is strategically aligned with the fundamentals of our Vision AI platform and strengthens our resources to advance our multimodal biometrics, identity intelligence, and biometric security. His appointment reinforces ROC’s commitment to developing American-made technology cultivated through rigorous science and engineered for real-world operations.”

Dr. Jain is among the most highly cited researchers in the history of computer science, with five decades of experience focused on translating research into practical applications, including foundational work in pattern recognition, biometrics, computer vision, and machine learning. His research has been patented, licensed, and deployed in operational environments and has informed identity technologies used across government, security, and commercial applications worldwide.

Dr. Brendan Klare, ROC Co-Founder and Chief Scientist commented, “Dr. Jain’s important scientific and engineering discoveries in pattern recognition are fundamental to the technologies, institutions, and researchers that continue to move this field forward. As ROC builds the next generation of identity intelligence, we are honored to receive steady guidance from a fundamental leader in pattern recognition and biometrics whose rigor, practical perspective, and lifelong commitment to meaningful impact have shaped so much of the field.”

The appointment of Dr. Jain adds a foundational scientific perspective to ROC’s Board at a pivotal stage in the Company’s growth. His guidance will help inform ROC’s research-led product development as it advances its Vision AI platform across national security, public safety, and commercial markets.

“I’ve dedicated my career to computer science and engineering research in order to advance pattern recognition focused on solving real-world operational challenges,” said Dr. Jain. “ROC’s mission to advance its biometric and identity intelligence is a natural extension of that work. I look forward to contributing my experience as the Company expands its technology capabilities, strengthens the ROC Vision AI platform, and executes on its long-term growth strategy.”

Dr. Anil Jain is a globally recognized pioneer in pattern recognition, computer vision, and biometrics. His research has been pivotal in transforming the biometrics industry. Dr. Jain spent most of his career at Michigan State University beginning in 1974 and currently serves as a University Distinguished Professor. He has authored many seminal papers and fifteen books, including Introduction to Biometrics, Handbook of Face Recognition, Handbook of Fingerprint Recognition and Algorithms for Clustering Data; he also has a dozen patents to his name. Dr. Jain served as editor-in-chief of IEEE Transactions on Pattern Analysis and Machine Intelligence, the most prestigious journal in the fields of computer vision and biometrics. He was elected to the U.S. National Academy of Engineering, and he also served as a member of the U.S. National Academies panels on Face Recognition Technology, Information Technology Laboratory Assessment, Whither Biometrics, and Improvised Explosive Devices. Additionally, Dr. Jain served on the United States Defense Science Board, the Forensic Science Standards Board, and the AAAS Latent Fingerprint Working Group. Further, Dr. Jain has mentored numerous researchers and industry leaders who have contributed to the commercialization and advancement of biometric and AI technologies worldwide. Dr. Jain holds a Bachelor of Technology from the Indian Institute of Technology, Kanpur, and an M.S. and Ph.D. in electrical engineering from The Ohio State University.  

For more information about this story, please visit the ROC blog.

About ROC

ROC is a leading U.S. developer and manufacturer of Vision AI, delivering sovereign biometrics, video analytics, and digital evidence through a unified platform. This enables agency and integrator partners to unlock faster, more accurate, and cost-efficient capabilities. At its core, ROC transforms raw pixels into real-time operational awareness for defense, public safety, and digital commerce. The Company is headquartered in Denver, Colo., with additional hubs in Grand Rapids, Mich., and Morgantown, W.V. For more information, please visit the Company’s website: www.roc.ai.

Forward-Looking Statements

This Press Release may contain forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident,” and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Therefore, caution must be exercised in relying on forward-looking statements as a number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: (i) the Company’s goals and strategies and (ii) the Company’s future business development, financial condition, and results of operations. Further information regarding these and other risks is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

Media inquiries:
Matt Aitken, VP of Marketing
media@roc.ai

Investor inquiries:
ir@roc.ai

Company to host conference call and webcast following the presentation on Tuesday, October 20, at 8:00 a.m. EDT

BOSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) — Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology, today announced that additional results from the OD-001 induction period of its Phase 2a trial in moderate to severe ulcerative colitis will be featured in an oral presentation at United European Gastroenterology (UEG) Week 2026, taking place October 17-20, in Barcelona, Spain.

The oral presentation details are as follows:

Title: Safety and Efficacy of OD-001, a First-in-class Oral RIPK2 Scaffolding Inhibitor, in Patients with Moderately to Severely Active Ulcerative Colitis: Results from a Phase 2a Trial (NCT06850727)
Presenter: Bruce Sands, M.D., M.S., Dr. Burrill B. Crohn Professor of Medicine and Chief, Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai
Presentation Number: OP197
Date and Time: Tuesday, October 20, at 9:00 a.m. CEST / 3:00 a.m. EDT
Room: UEG Forum

Odyssey will host a conference call and webcast on Tuesday, October 20, 2026, at 8:00 a.m. EDT to review additional data from the OD-001 induction period of the Phase 2a trial beyond those presented at UEG Week 2026. A live webcast will be available under “News and Events” in the Investors section of the Company’s website at www.odysseytx.com on the day of the event. A replay will be archived on the Events page for 180 days.

About Odyssey Therapeutics

Odyssey Therapeutics is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology. Since its founding in 2021, Odyssey has built a portfolio of internally discovered and developed medicines with its first program advancing through multiple clinical milestones. Odyssey’s portfolio leverages the scientific expertise of its team of experienced drug hunters and a comprehensive suite of tools to efficiently advance product candidates that the Company believes have the potential to induce deep and durable remission for patients across several inflammatory diseases with unmet need.

For more information, please visit www.odysseytx.com and follow Odyssey on LinkedIn or X.

Contacts

Benjamin Navon
Senior Director, Communications

For investors
investors@odysseytx.com

For media
media@odysseytx.com

EinStrong invests $2M in authID’s biometric identity technology to secure its mission to fight poverty and educational inequality

DENVER, Oct. 06, 2026 (GLOBE NEWSWIRE) — authID® (Nasdaq: AUID), a leading provider of biometric identity verification and authentication solutions, today announced a $2 million technology licensing, services, and support agreement with the EinStrong Charitable Foundation, an organization dedicated to alleviating poverty and providing secure and transparent support to vulnerable groups of people around the world.

To enable the further development of ESi, EinStrong’s universal ID, EinStrong paid $1 million for a non-exclusive authID technology license and has committed an additional $1 million for new biometric de-duplication functionality and engineering support.

EinStrong provides direct cash transfers            directly to underprivileged populations such as single mothers living in poverty, utilizing authID technology to positively determine the identities of recipients through biometric identification and verification. EinStrong’s program encourages the improvement of local environments and the progression of sustainable livelihoods, as well as assisting childhood education.

To enhance its ability to prevent fraud and ensure that funds are only provided to eligible recipients, EinStrong has made a significant commitment to the authID technology through investment and product roadmap alignment.

“For over two years we have been proud participants in EinStrong’s mission to assist less fortunate, at-risk communities,” commented Thomas Szoke, CEO of authID. “Their commitment to supporting impoverished societies has inspired our designers and developers to further enhance our tech, allowing them to deter fraudsters and duplicates, and put precious funds in the hands of deserving individuals.”

“We are excited about our business outlook and the execution of this important agreement,” added Szoke.   “Having now reduced our monthly cash operating expenses by roughly 40% as compared to the first quarter 2026, we start the fourth quarter from a leaner base that gives us real leverage as the business grows. We remain committed to disciplined execution and to pursuing the best path forward for authID, its customers and its shareholders.”

“Over the last two years, our use of authID’s biometric platform has given our sponsors the confidence to fund our mission knowing that their donations will go only to people in need,” commented Steven Cho, Chief Operating Officer of EinStrong. “By deepening our investment and partnership with authID, EinStrong will further extend its innovation and achieve even greater impact as we scale.”

EinStrong’s proprietary app enables donors to bypass the typical obstacles to philanthropy, with direct cash donations that most easily benefit needy families across multiple continents. authID has supported EinStrong’s mission through a seamless biometric identity experience that allows users to easily and securely assert their identities and gain access to and use donor funds.

About authID

authID® (Nasdaq: AUID) ensures enterprises “Know Who’s Behind the Device™” for every customer or employee login and transaction through its easy-to-integrate, patented, biometric identity platform. authID quickly and accurately verifies a user’s identity and eliminates any assumption of “who” is behind a device to prevent cybercriminals from compromising account openings or taking over accounts. Combining secure digital onboarding, biometric authentication, and account recovery with a fast, accurate, user-friendly experience, authID delivers biometric identity processing in 700ms, with a 1-to-1-billion false match rate and 1-to-many sub-second search capability. authID delivers all the benefits of biometric identity verification while ensuring complete privacy protection and regulatory compliance by storing no biometric data whatsoever. For more information, visit authid.ai.

authID Investor Relations 
investor-relations@authID.ai 

About the EinStrong Foundation

The EinStrong Foundation is a not-for-profit foundation started in 2019, headquartered in Southern California, with additional support from individuals and organizations in Asia and Europe. They invite other individuals, foundations, educational institutions, NGOs, and philanthropists to improve the economic, educational, and climate change objectives of people around the world. Their objective is to benefit a billion people globally in the next 5-10 years.

For more information, contact info@einstrong.org

Company authorized to repurchase up to all CHAD shares outstanding from time to time

CHAD brings Digital Credit 2.0 to income investors: a 13% annual dividend rate supported by a productive SOL treasury

BOCA RATON, FL, Oct. 06, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first U.S. public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced that its Board of Directors has authorized a repurchase program for its Variable Rate Series C Perpetual Preferred Stock (“CHAD”).

Under the program, the Company is authorized to repurchase up to all CHAD shares outstanding from time to time, including shares issued in the future. The authorization is not limited to the amount of CHAD currently outstanding and is not exhausted by prior repurchases, providing the Company with ongoing flexibility as CHAD grows.

The Company does not currently intend to repurchase CHAD. Its near-term objective remains for CHAD to establish itself at or around its $10.00 par value, and the Company does not intend to initiate repurchases before CHAD first reaches par. Thereafter, if CHAD trades below par, the Company may use the repurchase program opportunistically when it believes doing so represents an attractive use of capital.

“Our first objective is simple: get CHAD to par,” said Joseph Onorati, Chief Executive Officer of DeFi Development Corp. “We are not announcing that we intend to buy CHAD today. We are putting the infrastructure in place so that, once CHAD has established itself at par, we have another tool available if it subsequently trades below par.”

“We think about CHAD as a long-term funding platform, not a one-time issuance. This authorization reflects that. It covers every share outstanding today and automatically extends to CHAD we may issue in the future. As CHAD scales, we want the flexibility to both issue CHAD when the market values it appropriately and repurchase it when we believe the market is offering it back to us at an attractive discount.”

The Board authorization permits repurchases from time to time through open-market purchases or privately negotiated transactions, subject to applicable securities laws and other restrictions. The timing, price and amount of any repurchases will be determined at the Company’s discretion. The repurchase program has no fixed expiration date and does not obligate the Company to repurchase any particular number of shares.

Learn more about CHAD at www.defidevcorp.com/chad.

For more information, visit defidevcorp.com. To stay up to date with the latest developments and insights, subscribe to our blog.

About DeFi Development Corp.

DeFi Development Corp. (Nasdaq: DFDV) has adopted a treasury policy under which the principal holding in its treasury reserve is allocated to SOL. Through this strategy, the Company provides investors with direct economic exposure to SOL, while also actively participating in the growth of the Solana ecosystem. In addition to holding and staking SOL, DeFi Development Corp. operates its own validator infrastructure, generating staking rewards and fees from delegated stake. The Company is also engaged across decentralized finance (DeFi) opportunities and continues to explore innovative ways to support and benefit from Solana’s expanding application layer.

The Company is also an AI-powered online platform that connects the commercial real estate industry by providing value-add services and software subscriptions to multifamily and commercial property professionals, as the Company connects the increasingly complex ecosystem that stakeholders have to manage. The Company’s data and software offerings are generally offered on a subscription basis as software as a service.

Forward Looking Statements and Metrics

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, but are not limited to, statements regarding expected September 30, 2026 metrics and growth in SPS, NAV per share, SOL holdings and cash balances; anticipated changes in borrowings and liquidity; future SOL accumulation and per-share accretion; capital raising and deployment, the anticipated issuance price of shares under the ATM program, the intended use of proceeds, and the Company’s ability to expand its SOL treasury and increase revenue, and can be identified by words such as “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations, and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) fluctuations in the market price of SOL and any associated losses that the Company may incur as a result of a decrease in the market price of SOL; (ii) a failure for the demand for SOL, or activity on the SOL network, to continue to develop and grow as predicted in our DFDV Model or at all; (iii) volatility in our stock price, including due to future issuances of common stock and securities convertible into common stock; (iv) the effect of and uncertainties related to the ongoing volatility in interest rates; (v) our ability to achieve and maintain profitability in the future; (vi) the impact on our business of the regulatory environment and complexities of complying with such environment, including changes in securities laws or other laws or regulations; (vii) changes in the accounting treatment relating to the Company’s SOL holdings; (viii) our ability to respond to general economic conditions; (ix) our ability to manage our growth effectively and our expectations regarding the development and expansion of our business; (x) our ability to access sources of capital, including debt financing and other sources of capital to finance operations and growth; and (xi) other risks and uncertainties more fully described in the section captioned “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and other reports we file with the SEC.

As a result of these matters, changes in facts, assumptions not being realized, or other circumstances, the Company’s actual results may differ materially from the expected results discussed in the forward-looking statements contained in this press release. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

SPS and NAV per share are supplemental analytical measures used by management to assess the Company’s treasury strategy and economic exposure attributable to common shareholders. For purposes of this release, NAV reflects the value of SOL and SOL equivalents, plus cash and cash equivalents, less SOL-denominated liabilities, outstanding principal of out-of-the-money convertible debt, other debt, and the aggregate notional amount of preferred equity. NAV per share reflects that amount divided by adjusted common shares outstanding, which includes ordinary shares outstanding, shares underlying restricted stock units and vested options, and applicable dilution from assumed exercise of in-the-money warrants and conversion of in-the-money convertible securities. Related adjustments to NAV reflect assumed warrant exercise proceeds and the removal of debt assumed converted, as applicable, to avoid double counting. SPS expresses the corresponding net SOL exposure per adjusted common share, with the SPS growth comparison applying the updated, liability-adjusted methodology and a SOL reference price to both measurement dates. These measures depend on valuation and capital structure assumptions and do not represent GAAP book value per share, liquidation proceeds, or shareholder investment returns. Preliminary estimates remain subject to completion of the Company’s financial close and verification of underlying balances and share counts, and final results may differ materially.

Investor Contact:
ir@defidevcorp.com

Media Contact:
press@defidevcorp.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.